Document Type
Journal Article
Publication Date
1-1-2016
Journal
Oxidative Medicine and Cellular Longevity
Volume
2016
Inclusive Pages
1840513
DOI
10.1155/2016/1840513
Abstract
Chronic ethanol-induced downregulation of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α) and upregulation of peroxisome proliferator-activated receptor gamma coactivator 1-beta (PGC1β) affect hepatic lipid oxidation and lipogenesis, respectively, leading to fatty liver injury. Low-ω3 fatty acid (Low-ω3FA) that primarily regulates PGC1α and soy protein (SP) that seems to have its major regulatory effect on PGC1β were evaluated for their protective effects against ethanol-induced hepatosteatosis in rats fed with Lieber-deCarli control or ethanol liquid diets with high or low ω3FA fish oil and soy protein. Low-ω3FA and SP opposed the actions of chronic ethanol by reducing serum and liver lipids with concomitant decreased fatty liver. They also prevented the downregulation of hepatic Sirtuin 1 (SIRT1) and PGC1α and their target fatty acid oxidation pathway genes and attenuated the upregulation of hepatic PGC1β and sterol regulatory element-binding protein 1c (SREBP1c) and their target lipogenic pathway genes via the phosphorylation of 5' adenosine monophosphate-activated protein kinase (AMPK). Thus, these two novel modulators attenuate ethanol-induced hepatosteatosis and consequent liver injury potentially by regulating the two opposing lipid oxidation and lipogenic pathways.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
APA Citation
Reyes-Gordillo, K., Shah, R., Varatharajalu, R., Garige, M., Leckey, L. C., & Lakshman, M. R. (2016). Low-ω3 Fatty Acid and Soy Protein Attenuate Alcohol-Induced Fatty Liver and Injury by Regulating the Opposing Lipid Oxidation and Lipogenic Signaling Pathways.. Oxidative Medicine and Cellular Longevity, 2016 (). http://dx.doi.org/10.1155/2016/1840513
Peer Reviewed
1
Open Access
1
Comments
Reproduced with permission of Hindawi Publishing Corp. Oxidative Medicine and Cellular Longevity